Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Many medications may be linked to cognitive disorders, but most lack warnings on labels.

"Clinically proven" claims require strict testing and adherence to guidelines for trust and authenticity.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

Cleanroom workers in a battery factory have worse skin and eye conditions due to the very dry environment.

Hair loss can cause significant social and emotional issues, especially for women and young men.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The ginseng market has potential for growth and needs new products and better marketing.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Men have more severe COVID-19 outcomes than women.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.